Nirogacestat hydrobromide approved to treat desmoid tumours  – GOV.UK

The Medicines and Healthcare products Regulatory Agency (MHRA) has today (7 January 2026) approved the medicine Nirogacestat hydrobromide (Ogsiveo) for the treatment of progressing desmoid tumours in adults. 

Desmoid tumours are tumours…